TGF β RIII Antibodies

Santa Cruz Biotechnology delivers a wide array of TGF β RIII monoclonal antibodies for research focused on understanding this important receptor. TGF β RIII Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TGF β RIII, also known as betaglycan, is a co-receptor for transforming growth factor-beta (TGF-β) that plays a crucial role in modulating cellular responses to TGF-β signaling. The co-receptor participates in various biological processes, including cell proliferation, differentiation, and extracellular matrix production. TGF β RIII has significant implications in developmental biology and disease states such as fibrosis and cancer. Understanding TGF β RIII function is essential for elucidating its contributions to cellular pathways. Research with TGF β RIII monoclonal antibodies can advance understanding of TGF-β signaling mechanisms. Exploring TGF β RIII's role in disease progression and development can lead to meaningful discoveries. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to make significant contributions to scientific knowledge in TGF-β signaling pathways.